Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome

Obstetrics and Gynecology

Volumn 89, Issue 4, 1997, Pages 549-555

  Branch, D Ware ^a   Silver, Robert ^b   Pierangeli, Silvia ^b   Van Leeuwen, Ingeborg ^b   Harris, E Nigel ^b  

^a Medical Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SPONTANEOUS ABORTION;

ABORTION, HABITUAL; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS COAGULATION INHIBITOR; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 0031128310     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(97)00065-3     Document Type: Article

References (26)

1. 1. Petri M, Golbus M, Anderson R, Whiting-O'Keefe Q, Corash L, Hellmann D. Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion: A controlled prospective study of 44 women. Arthritis Rheum 1987;30:601-6.
2. 2. Barbui T, Cortelazzo S, Galli M, Parazzini F, Radici E, Rossi E, et al. Antiphospholipid antibodies in early repeated abortions: A case-controlled study. Fertil Steril 1988;50:589-92.
3. 3. Parazzini F, Acaia B, Faden D, Lovotti M, Marelli G, Cortelazzo S. Antiphospholipid antibodies and recurrent abortion. Obstet Gynecol 1991;77:854-8.
4. 4. Out HJ, Bruinse HW, Christiaens GC, van Vliet M, Meilof JF, de Groot PG, et al. Prevalence of antiphospholipid antibodies in patients with fetal loss. Ann Rheum Dis 1991;50:553-7.
5. 5. Harris EN. Syndrome of the black swan. Br J Rheumatol 1986;26: 324-6.
6. 6. Alarcon-Segovia D, Deleze M, Oria CV, Sanchez-Guerrero J, Gomez-Pacheco L, Cabiedes J, et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective study of 500 consecutive cases. Medicine 1989;68: 353-63.
7. 7. Asherson RA, Khamashta MA, Ordi-Ros J, Derksen RH, Machin SJ, Barquinero J, et al. The "primary" antiphospholipid syndrome: Major clinical and serological features. Medicine 1989;68:366-74.
8. 8. Branch DW, Silver RM, Blackwell JL, Reading JC, Scott JR. Out-come of treated pregnancies in women with antiphospholipid syndrome: An update of the Utah experience. Obstet Gynecol 1992;4:614-20.
9. 9. Branch DW, Rote NS, Dostal DA, Scott JR. Association of lupus anticoagulant with antibody against phosphatidylserine. Clin Immunol Immunopathol 1987;42:63-75.
10. 10. Rote NS, Dostal-Johnson D, Branch DW. Antiphospholipid antibodies and recurrent pregnancy loss: Correlation between the activated partial thromboplastin time and antibodies against phosphatidylserine and cardiolipin. Am J Obstet Gynecol 1990;163:575-84.
11. 11. Gharavi AE, Harris EN, Asherson RA, Hughes GRV. Anticardiolipin antibodies: Isotype distribution and phospholipid specificity. Ann Rheum Dis 1987;46:1-6.
12. 12. Kwak JYH, Gilman-Sachs A, Beaman KD, Beer AE. Autoantibodies in women with primary recurrent spontaneous abortion of unknown etiology. J Reprod Immunol 1992;22:15-31.
13. 13. Bahar AM, Kwak JYH, Beer AE, Kim JH, Nelson LA, Beaman KD, et al. Antibodies to phospholipids and nuclear antigens in non-pregnant women with unexplained spontaneous abortions. J Reprod Immunol 1993;24:213-22.
14. 14. Matzner W, Chong P, Xu G, Ching W. Characterization of antiphospholipid antibodies in women with recurrent spontaneous abortions. J Reprod Med 1994;39:27-30.
15. 15. Ruiz JE, Cubillos J, Mendoza JC, Espinel FJ, Kwak JYH, Beer AE. Autoantibodies to phospholipids and nuclear antigens in non-pregnant and pregnant Colombian women with recurrent spontaneous abortions. J Reprod Immunol 1995;28:41-51.
16. 16. Silver RM, Draper ML, Scott JR, Lyon JL, Reading J, Branch DW. Clinical consequences of antiphospholipid antibodies: An historic cohort study. Obstet Gynecol 1994;83:372-7.
17. 17. Martin BA, Branch DW, Rodgers GM. The preparation of a partial thromboplastin reagent from bovine brain. Blood Coagul Fibrinolysis 1992;3:287-94.
18. 18. Martin BA, Branch DW, Rodgers GM. Sensitivity of the activated partial thromboplastin time, the dilute Russell's viper venom time, and the kaolin clotting time for the detection of the lupus anticoagulant: A direct comparison using plasma dilutions. Blood Coagul Fibrinolysis 1996;7:31-8.
19. 19. Harris EN. The second international anti-cardiolipin standardization workshop/The Kingston anti-phospholipid antibody study (KAPS) group. Am J Clin Pathol 1990;94:476-84.
20. 20. Harris EN, Pierangeli SS, Birch D. Anticardiolipin wet workshop report: Fifth International Symposium on Antiphospholipid Antibodies. Am J Clin Pathol 1994;101:616-24.
21. 21. Aoki K, Hayashi Y, Hirao Y, Yagami Y. Specific antiphospholipid antibodies as a predictive variable in patients with recurrent pregnancy loss. Am J Reprod Immunol 1993;29:82-7.
22. 22. Harris EN, Spinnato JA. Should anticardiolipin tests be performed in otherwise healthy pregnant women? Am J Obstet Gynecol 1991;165:1272-7.
23. 23. Ober C, Darrison T, Harlow L, Elias S, Gleicher N. Autoantibodies and pregnancy history in a healthy population. Am J Obstet Gynecol 1993;169:143-7.
24. 24. Silver RM, Porter TF, van Leeuwen I, Jeng G, Scott JR, Branch DW. Anticardiolipin antibodies: Clinical consequences of "low titers." Obstet Gynecol 1996;87:494-500.
25. 25. Kwak JYH, Gilman-Sachs A, Beaman KD, Beer AE. Reproductive outcome in women with recurrent spontaneous abortions of alloimmune and autoimmune causes: Preconception versus postconception treatment. Am J Obstet Gynecol 1992;166:1787-95.
26. 26. Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995;332:1330-5.